Michaela Miškovičová, MD, PhD graduated in 2011 from the General Medicine program at the 1st
Faculty of Medicine of Charles University in Prague, where she has served as an assistant professor since 2014, and in 2021
she completed her doctoral postgraduate studies in biochemistry and pathobiochemistry, focusing on
innovative diagnostics of colorectal carcinoma. Since 2011, she has worked at the Department of Oncology of the
General University Hospital and the First Faculty of Medicine of Charles University in Prague, where she also attained
specialized certification in clinical oncology. Within the Genetic Clinic, she focused on
long-term monitoring and counseling for healthy individuals with an increased risk of developing neoplastic
diseases. Her primary focus is the treatment of breast cancer, selected groups of patients
with genetically determined neoplastic diseases, and an outpatient clinic for neuroendocrine tumors. She continues to be actively involved in teaching students and in research projects in cooperation with the First Faculty of Medicine of Charles University in Prague. She has experience working on Phase I-IV clinical trials. She is a member of ESMO (European Society for Medical Oncology), the Czech Medical Association of J.E. Purkyně (ČLS JEP), the Oncology Immunology Section of ČLS JEP, the Cooperative Group for Neuroendocrine Tumors in the Czech Republic, and the Slovak Medical Society. Since September 2022, she has been working as the Head of the Department of Oncology at the University Hospital Nitra.